Preston Sullivan, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5201 Olympic Dr Ste 110, Gig Harbor, WA 98335 Phone: 253-432-3238 Fax: 253-509-0217 |
Mark W Taylor, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4700 Point Fosdick Drive Nw, Ste 112, Gig Harbor, WA 98335 Phone: 253-759-5555 Fax: 253-830-5420 |
News Archive
Chronic fatigue syndrome (CFS) is a potentially long-lasting illness that can cause considerable distress and disability. Some estimates suggest it may affect as many as 1 in 100 of the population globally.
Humanin is a potential therapeutic agent for Alzheimer's disease, and its derivative, S14G-humanin, is 1 000-fold stronger in its neuroprotective effect against Alzheimer's disease-relevant insults. Al-though effective, the detailed molecular mechanism through which S14G-humanin exerts its effects remains unclear.
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Unfortunately, some of the most effective therapies also have toxic side effects that can pose serious health risks and reduce quality of life. In the October issue of Mayo Clinic Proceedings, two articles authored by Mayo researchers address the issue of how to balance the risks and benefits associated with MM treatments.
"President Barack Obama said Wednesday that he is committed to helping keep Democrats in governors' offices across the country and move their states forward, starting with changes to the health care system," The Associated Press reports. In his comments at a Democratic Governors Association fundraiser in Washington, Obama talked about the "challenging times for the states and the nation."
A.P. Pharma, a specialty pharmaceutical company, today announced that on October 26, 2009, the Company received notice that the Nasdaq Listing Qualifications Panel (Panel) has granted the Company's request to transfer the listing of the Company's common stock from The Nasdaq Global Market to The Nasdaq Capital Market, which will take effect with the opening of the market on Wednesday, October 28, 2009.
› Verified 5 days ago